News
11h
News-Medical.Net on MSNResidual inflammation can linger in psoriasis patients despite skin treatmentNew research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...
Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting ...
The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
Psoriasis, with its systemic inflammatory nature and high risk of cardiovascular disease, could provide a valuable framework ...
And if you’re anything like me (read: always curious about the latest wellness trend), you might be wondering whether light ...
How does one live with psoriasis? From medication to nutrition (and beyond), Olivia Marks goes in search of clear answers.
While patients with psoriasis -- a chronic skin condition -- respond well to treatment with biologics, inflammation can ling ...
Kathy Reagan Young steps out of the shower in her Virginia Beach home, towels off, dons a pair of protective goggles and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results